Vaccine equity refers to fair and impartial access to vaccines for all individuals, irrespective of their geographic location, socioeconomic status, or background. Achieving vaccine equity is crucial to effectively combatting infectious diseases on a global scale, ensuring that vulnerable populations are not left behind in the fight against illnesses.
This concept emphasizes the distribution of vaccines in a manner that prioritizes those most in need, acknowledging and addressing systemic barriers that hinder access to healthcare. By addressing factors such as affordability, infrastructure, education, and prioritizing marginalized communities, vaccine equity aims to create a level playing field where everyone has equal opportunities to receive life-saving vaccinations.
Efforts to promote vaccine equity involve collaborations among governments, healthcare organizations, pharmaceutical companies, and international bodies to develop strategies that guarantee fair vaccine distribution worldwide. This approach not only safeguards individual health but also contributes to global health security by reducing the risk of outbreaks and fostering a more resilient and healthier society. Achieving vaccine equity is a critical step towards building a more inclusive and healthier world for all.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan